May 9, 2022 02:05 PM EDT
Pharma
Law

Wrong par­ty, wrong court: Mod­er­na fights back against patent in­fringe­ment case sur­round­ing its Covid-19 vac­cine

Nicole DeFeudis

Editor

Ar­bu­tus and Genevant filed a law­suit back in Feb­ru­ary ac­cus­ing Mod­er­na of steal­ing the for­mer’s patent­ed lipid nanopar­ti­cle tech­nol­o­gy for its Covid-19 vac­cine. On Fri­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times